Twitter | Pretraživanje | |
Xconomy
Annovis Bio Gets $12M in IPO to Target Trio of Neurotoxic Proteins - by
A Philadelphia-area biotech is developing therapies for neurodegenerative diseases it says have the potential to perform better than others by targeting
Xconomy Xconomy @Xconomy
Reply Retweet Označi sa "sviđa mi se" More